GEG vs PBH ᐉ Comparison: Which is Better to Invest?
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEG is a Hold and PBH is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GEG’s FA Score shows that 0 FA rating(s) are green whilePBH’s FA Score has 1 green FA rating(s).
- GEG’s FA Score: 0 green, 5 red.
- PBH’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PBH’s TA Score shows that 5 TA indicator(s) are bullish.
- PBH’s TA Score: 5 bullish, 5 bearish.
Price Growth
GEG (@Investment Managers) experienced а -2.30% price change this week, while PBH (@Pharmaceuticals: Other) price change was +4.64% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +2.14%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +22.24%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.33%. For the same industry, the average monthly price growth was +27.90%, and the average quarterly price growth was +18903.16%.
Reported Earning Dates
GEG is expected to report earnings on May 03, 2024.
PBH is expected to report earnings on Aug 01, 2024.
Industries' Descriptions
@Investment Managers (+2.14% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
@Pharmaceuticals: Other (-1.33% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| GEG | PBH | GEG / PBH | |
| Capitalization | 60.7M | 3.6B | 2% |
| EBITDA | 2.4M | 10.8M | 22% |
| Gain YTD | -4.124 | 16.335 | -25% |
| P/E Ratio | 2.31 | 14.90 | 16% |
| Revenue | 11.1M | 1.13B | 1% |
| Total Cash | 123M | 63.6M | 193% |
| Total Debt | 64.4M | 1.21B | 5% |
GEG | PBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 76 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 7 | |
SMR RATING 1..100 | 59 | 91 | |
PRICE GROWTH RATING 1..100 | 72 | 49 | |
P/E GROWTH RATING 1..100 | 96 | 55 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEG's Valuation (56) in the Internet Software Or Services industry is in the same range as PBH (85) in the Pharmaceuticals Other industry. This means that GEG’s stock grew similarly to PBH’s over the last 12 months.
PBH's Profit vs Risk Rating (7) in the Pharmaceuticals Other industry is significantly better than the same rating for GEG (100) in the Internet Software Or Services industry. This means that PBH’s stock grew significantly faster than GEG’s over the last 12 months.
GEG's SMR Rating (59) in the Internet Software Or Services industry is in the same range as PBH (91) in the Pharmaceuticals Other industry. This means that GEG’s stock grew similarly to PBH’s over the last 12 months.
PBH's Price Growth Rating (49) in the Pharmaceuticals Other industry is in the same range as GEG (72) in the Internet Software Or Services industry. This means that PBH’s stock grew similarly to GEG’s over the last 12 months.
PBH's P/E Growth Rating (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for GEG (96) in the Internet Software Or Services industry. This means that PBH’s stock grew somewhat faster than GEG’s over the last 12 months.
| PBH | |
|---|---|
| RSI ODDS (%) | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 68% |
| TrendMonth ODDS (%) | 2 days ago 48% |
| Advances ODDS (%) | 2 days ago 63% |
| Declines ODDS (%) | 8 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 59% |
| Aroon ODDS (%) | 2 days ago 41% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGTHX | 68.84 | 1.29 | +1.91% |
| American Funds Growth Fund of Amer A | |||
| OGGFX | 19.20 | 0.36 | +1.91% |
| JPMorgan Small Cap Growth I | |||
| GTFPX | 27.48 | 0.33 | +1.22% |
| Goldman Sachs International Eq ESG P | |||
| USRAX | 30.05 | 0.29 | +0.97% |
| Horizon Multi-Factor U.S. Equity Inv | |||
| MBBIX | 11.53 | 0.08 | +0.70% |
| MassMutual Balanced I | |||
GEG and
Correlation & Price change
A.I.dvisor tells us that GEG and PFG have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GEG and PFG's prices will move in lockstep.
| Ticker / NAME | Correlation To GEG | 1D Price Change % | ||
|---|---|---|---|---|
| GEG | 100% | +0.54% | ||
| PFG - GEG | 24% Poorly correlated | +0.20% | ||
| PSEC - GEG | 23% Poorly correlated | +1.39% | ||
| CION - GEG | 23% Poorly correlated | +0.62% | ||
| VRTS - GEG | 22% Poorly correlated | +0.59% | ||
| STEP - GEG | 22% Poorly correlated | -1.21% | ||
More | ||||
PBH and
Correlation & Price change
A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.
| Ticker / NAME | Correlation To PBH | 1D Price Change % | ||
|---|---|---|---|---|
| PBH | 100% | +2.03% | ||
| PAHC - PBH | 36% Loosely correlated | +4.29% | ||
| IRWD - PBH | 32% Poorly correlated | +3.10% | ||
| EBS - PBH | 26% Poorly correlated | +6.02% | ||
| BGXX - PBH | 24% Poorly correlated | -0.20% | ||
| LFCR - PBH | 24% Poorly correlated | +2.54% | ||
More | ||||